人造 发表于 2025-3-23 12:34:41

Submitted on: 29 August 2004.
Revised on: 02 October 2004.
Accepted on: 18 October 2004.
NULL

Mystic 发表于 2025-3-23 14:25:08

Submitted on: 28 July 2013.
Revised on: 08 August 2013.
Accepted on: 01 September 2013.
Pharmacoeconomics-Open---SPRINGER INT PUBL AG

大暴雨 发表于 2025-3-23 19:34:12

Submitted on: 17 August 1998.
Revised on: 14 September 1998.
Accepted on: 27 September 1998.
NULL

填料 发表于 2025-3-24 01:03:44

http://reply.papertrans.cn/3/245/24401/24401-14.png

滔滔不绝的人 发表于 2025-3-24 04:52:43

http://reply.papertrans.cn/3/245/24401/24401-15.png

打击 发表于 2025-3-24 06:39:00

http://reply.papertrans.cn/3/245/24401/24401-16.png

勉强 发表于 2025-3-24 12:56:26

Submitted on: 19 November 2001.
Revised on: 17 December 2001.
Accepted on: 31 December 2001.
Pharmacoeconomics-Open---SPRINGER INT PUBL AG

Moderate 发表于 2025-3-24 18:55:42

Submitted on: 04 July 2019.
Revised on: 23 July 2019.
Accepted on: 15 August 2019.
Pharmacoeconomics-Open---SPRINGER INT PUBL AG

尽管 发表于 2025-3-24 19:15:14

http://reply.papertrans.cn/3/245/24401/24401-19.png

眨眼 发表于 2025-3-25 03:00:03

Submitted on: 28 June 2017.
Revised on: 22 July 2017.
Accepted on: 06 August 2017.
Pharmacoeconomics-Open---SPRINGER INT PUBL AG
页: 1 [2] 3 4
查看完整版本: ESCI期刊Pharmacoeconomics-Open 2024/2025影响因子:2.177 (PHARMACOECON-OPEN) (2509-4262). (ECONOMICS)(经济学)Emerging Sources Cita